Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

Study ID: NCT02610439
Start Date: 2014-03-25
End Date: 2100-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

575

Intervention / Treatment

Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

Study ID: NCT05447923
Start Date: 2022-05-22
End Date: 2030-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment

Educational Intervention

Fecal Immunochemical Test

Patient Navigation

Administration Questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Study ID: NCT05493566
Start Date: 2022-11-01
End Date: 2027-01-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

15

Intervention / Treatment

Aldesleukin

Pembrolizumab

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

Study ID: NCT02634645
Start Date: 2015-01
End Date: 2027-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5000

Intervention / Treatment

Endoscopic eradication therapies (EET)

Esophagectomy

Chemotherapy

Radiation

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Study ID: NCT05486572
Start Date: 2023-11-03
End Date: 2031-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

4700

Intervention / Treatment

Abbreviated Magnetic Resonance Imaging with serum AFP

Abdominal Ultrasound Screening with serum AFP

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Study ID: NCT02393157
Start Date: 2015-08-21
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Obinutuzumab

Liposomal ARA-C

Ifosfamide

Carboplatin

Etoposide

Sponsor

New York Medical College

Source: clinicaltrials.gov

Share:
Add to list

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Study ID: NCT03996265
Start Date: 2019-06-27
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

422

Intervention / Treatment

Biospecimen Collection

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Administration Questionnaire

Sponsor

University of Rochester NCORP Research Base

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning

Study ID: NCT06409000
Start Date: 2021-01-19
End Date: 2028-08-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

26

Intervention / Treatment

Electronic Health Record Review

Three-Dimensional Imaging

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Study ID: NCT04957511
Start Date: 2021-06-29
End Date: 2026-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

Viome

Source: clinicaltrials.gov

Share:
Add to list

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

Study ID: NCT06065371
Start Date: 2024-11-20
End Date: 2026-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Capecitabine

Sacituzumab govetican

Sponsor

Henry Ford Health System

Source: clinicaltrials.gov

Share:
Add to list